Burning Rock Biotech Ltd Logo

Burning Rock Biotech Ltd

Offers NGS-based diagnostics for precision oncology, from detection to clinical trial support.

BNR | US

Overview

Corporate Details

ISIN(s):
US12233L1070
LEI:
Country:
United States of America
Address:
NO. 5 XINGDAO RING ROAD NORTH,, 510005 GUANGZHOU, GUANGDONG
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Burning Rock Biotech Ltd. is a global diagnostics company specializing in precision oncology through the application of next-generation sequencing (NGS) technology. The company develops and offers an internally developed portfolio of NGS-based diagnostic assays for both tissue and liquid biopsy samples, providing individualized cancer treatment guidance. Its solutions cover the entire precision oncology development cycle, from early detection to treatment selection and monitoring. Burning Rock also leverages its robust in-house database to facilitate clinical trial studies and research, providing dedicated genomic data and clinical trial solutions to pharmaceutical partners.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Burning Rock Biotech Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Burning Rock Biotech Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Burning Rock Biotech Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
OPKO HEALTH, INC. Logo
A biopharma and diagnostics firm offering novel therapies and full-service clinical lab testing.
United States of America OPK
Opthea Ltd Logo
Biopharma that discontinued its wet AMD therapy after its lead drug failed Phase 3 trials.
United States of America OPT
OPTUS Pharmaceutical Co., Ltd. Logo
Develops and manufactures ophthalmic solutions for dry eye, infections, and inflammation.
South Korea 131030
Opus Genetics, Inc. Logo
Developing gene therapies for inherited retinal diseases and other blinding conditions.
United States of America IRD
ORAGENICS INC Logo
Biotech developing intranasal drugs for concussion and other brain disorders.
United States of America OGEN
Oramed Pharmaceuticals Inc. Logo
Develops oral drug delivery systems to turn injectable drugs, like insulin, into oral therapies.
Israel ORMP
ORASURE TECHNOLOGIES INC Logo
Develops and distributes point-of-care diagnostic tests and sample collection devices.
United States of America OSUR
Orexo Logo
Develops pharmaceuticals & digital health for opioid use disorder in the US market.
Sweden ORX
ORGANIGRAM GLOBAL INC. Logo
Licensed producer of indoor-grown cannabis and derived products for medical & recreational consumers.
United States of America OGI
Organon & Co. Logo
A global healthcare company focused on women's health, biosimilars, and established brands worldwide.
United States of America OGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.